Prostate Cancer (Adenocarcinoma)

Oncology
0
Pipeline Programs
3
Companies
3
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

EXACT Therapeutics
EXACT TherapeuticsNorway - Oslo
1 program
6 month, prospective, interventional single-arm safety and effectiveness studyN/A1 trial
Active Trials
NCT07339943Recruiting7Est. Dec 2027
Blue Earth Therapeutics
1 program
Positron Emission TomographyN/A1 trial
Active Trials
NCT06862856RecruitingEst. Dec 2026
AM-Pharma
AM-PharmaNetherlands - Utrecht
1 program
preop virtual 3D modelN/A1 trial
Active Trials
NCT07129551RecruitingEst. Dec 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
AM-Pharmapreop virtual 3D model
Blue Earth TherapeuticsPositron Emission Tomography
EXACT Therapeutics6 month, prospective, interventional single-arm safety and effectiveness study

Clinical Trials (3)

Total enrollment: 7 patients across 3 trials

NCT07129551AM-Pharmapreop virtual 3D model

Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted Surgery

Start: Jan 2026Est. completion: Dec 2028
N/ARecruiting
NCT06862856Blue Earth TherapeuticsPositron Emission Tomography

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Start: May 2025Est. completion: Dec 2026
N/ARecruiting
NCT07339943EXACT Therapeutics6 month, prospective, interventional single-arm safety and effectiveness study

Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness

Start: Apr 2025Est. completion: Dec 20277 patients
N/ARecruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 actively recruiting trials targeting 7 patients
3 companies competing in this space